Expert second opinions for pericardial disease. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Pericardial Disease encompasses conditions affecting the sac surrounding the heart, including constrictive pericarditis, recurrent pericardial effusions, and pericardial tumors. If you are facing a decision about pericardial disease, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Pericardial disease encompasses conditions affecting the sac surrounding the heart, including constrictive pericarditis, recurrent pericardial effusions, and pericardial tumors. Constrictive pericarditis — where the pericardium thickens and restricts heart filling — is the primary surgical indication.
Differentiating constrictive pericarditis from restrictive cardiomyopathy remains one of the most challenging diagnoses in cardiology. Pericardiectomy can be curative for constriction but carries significant risk and is technically demanding. Confirming the diagnosis and ensuring surgical candidacy requires expert evaluation.
Surgery for pericardial disease depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Differentiating constrictive pericarditis from restrictive cardiomyopathy remains one of the most challenging diagnoses in cardiology. Pericardiectomy can be curative for constriction but carries significant risk and is technically demanding. Confirming the diagnosis and ensuring surgical candidacy requires expert evaluation.
Operative mortality for pericardial disease-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for pericardial disease depends on anatomy, comorbidities, age, and personal goals. Confirming constrictive vs restrictive physiology. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.